RxDoctor Payments Data

Elisa Conway

Family · Linwood, NJNPI 1275950230

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.4% of the total across 291 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,227, 9.1 times the $136 reported in 2021. Among family clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,917in general payments, 2019–2025

Across 291 payments — averaging $13.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma Inc.$759
  • AbbVie$583
  • Novartis$356
  • Johnson & Johnson$327
  • Arcutis Biotherapeutics, Inc.$265
  • E.r. Squibb & Sons, L.L.C.$257
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,61892%
  • Education$2998%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,917 in reported general payments places this provider in the 90th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey →

Medicare billing

Part B allowed, 2024
$73,632
Medicare patients
311
Services billed
1,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab23$104,373
Humira PenAdalimumab13$92,578
Humira(Cf) PenAdalimumab11$74,090
Dupixent SyringeDupilumab14$51,307
Tretinoin164$4,935
Tacrolimus24$4,468
Azelaic Acid15$1,781
Clobetasol Propionate32$1,778
Metronidazole28$1,766
Ketoconazole76$1,673
Clindamycin Phosphate51$1,517
Ammonium Lactate62$1,002
Mometasone Furoate42$998
Triamcinolone Acetonide97$927
Fluorouracil14$830

Paid to pharmacies, not to this prescriber.

Other family in Linwood

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →